A detailed history of Creative Planning transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Creative Planning holds 27,812 shares of ATAI stock, worth $31,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,812
Previous 28,657 2.95%
Holding current value
$31,705
Previous $38,000 15.79%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$1.16 - $1.64 $980 - $1,385
-845 Reduced 2.95%
27,812 $32,000
Q2 2024

Aug 15, 2024

BUY
$1.27 - $2.6 $3,613 - $7,397
2,845 Added 11.02%
28,657 $38,000
Q1 2024

May 10, 2024

SELL
$1.5 - $2.19 $3,609 - $5,269
-2,406 Reduced 8.53%
25,812 $50,000
Q4 2023

Feb 14, 2024

BUY
$1.04 - $1.55 $2,502 - $3,729
2,406 Added 9.32%
28,218 $39,000
Q1 2023

May 15, 2023

BUY
$1.17 - $2.7 $16,888 - $38,974
14,435 Added 126.88%
25,812 $46,000
Q4 2022

Feb 10, 2023

BUY
$2.38 - $3.55 $630 - $940
265 Added 2.38%
11,377 $30,000
Q3 2022

Nov 03, 2022

SELL
$3.14 - $4.87 $314 - $487
-100 Reduced 0.89%
11,112 $37,000
Q2 2022

Aug 15, 2022

SELL
$3.03 - $5.32 $5,787 - $10,161
-1,910 Reduced 14.56%
11,212 $41,000
Q1 2022

May 16, 2022

BUY
$4.66 - $7.66 $61,148 - $100,514
13,122 New
13,122 $67,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $189M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.